These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15283464)

  • 1. A cholesterol biosynthesis inhibitor from Rhizopus oryzae.
    Kim HJ; Yim SH; Lee IS
    Arch Pharm Res; 2004 Jun; 27(6):624-7. PubMed ID: 15283464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes.
    Gebhardt R
    Lipids; 1993 Jul; 28(7):613-9. PubMed ID: 8394977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts.
    Gebhardt R
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1122-8. PubMed ID: 9732368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment.
    Gebhardt R
    Phytother Res; 2002 Jun; 16(4):368-72. PubMed ID: 12112295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cholesterol absorption and biosynthesis by decoctions of Annona cherimola leaves.
    Falé PL; Ferreira C; Maruzzella F; Helena Florêncio M; Frazão FN; Serralheiro ML
    J Ethnopharmacol; 2013 Nov; 150(2):718-23. PubMed ID: 24095697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis.
    Shin BA; Kim YR; Lee IS; Sung CK; Hong J; Sim CJ; Im KS; Jung JH
    J Nat Prod; 1999 Nov; 62(11):1554-7. PubMed ID: 10579872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes.
    Gebhardt R
    Arzneimittelforschung; 1991 Aug; 41(8):800-4. PubMed ID: 1781801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of sterol synthesis. Effects of dietary 5 alpha-cholest-8(14)-en-3 beta-ol-15-one on early enzymes in hepatic cholesterol biosynthesis.
    Miller LR; Raulston DL; Schroepfer GJ
    Chem Phys Lipids; 1988 Jul; 47(3):177-86. PubMed ID: 2901919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent.
    Amin D; Gustafson SK; Weinacht JM; Cornell SA; Neuenschwander K; Kosmider B; Scotese AC; Regan JR; Perrone MH
    Pharmacology; 1993; 46(1):13-22. PubMed ID: 8434028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocholesterolemic activity of synthetic and natural tocotrienols.
    Pearce BC; Parker RA; Deason ME; Qureshi AA; Wright JJ
    J Med Chem; 1992 Oct; 35(20):3595-606. PubMed ID: 1433170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of substrate supply in the regulation of cholesterol biosynthesis in rat hepatocytes.
    Pullinger CR; Gibbons GF
    Biochem J; 1983 Mar; 210(3):625-32. PubMed ID: 6870798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis.
    Endo A; Hasumi K; Nakamura T; Kunishima M; Masuda M
    J Antibiot (Tokyo); 1985 Mar; 38(3):321-7. PubMed ID: 3839224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conformation and CETP inhibitory activity of [10]-dehydrogingerdione isolated from Zingiber officinale.
    Choi SY; Park GS; Lee SY; Kim JY; Kim YK
    Arch Pharm Res; 2011 May; 34(5):727-31. PubMed ID: 21656357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols.
    Pearce BC; Parker RA; Deason ME; Dischino DD; Gillespie E; Qureshi AA; Volk K; Wright JJ
    J Med Chem; 1994 Feb; 37(4):526-41. PubMed ID: 8120870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in the inhibiting effect of fluvastatin, a new inhibitor of HMG-CoA reductase, on cholesterol biosynthesis.
    Yamamoto A; Itoh S; Hoshi K; Ichihara K
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):325-34. PubMed ID: 7712108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevalonic acid analogs as inhibitors of cholesterol biosynthesis.
    DeBold CR; Elwood JC
    J Pharm Sci; 1981 Sep; 70(9):1007-10. PubMed ID: 6101142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.